Your browser doesn't support javascript.
loading
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia.
Roberts, Thomas; Uwenedi, Grace; Bruton, Rachel; McIlroy, Graham; Damery, Sarah; Sylla, Panagiota; Logan, Nicola; Scott, Sam; Lau, May; Elzaidi, Ahmed; Plass, Siobhan; Mallick, Soumyajit; Spencer, Katie; Stephens, Christine; Bentley, Christopher; Pratt, Guy; Zuo, Jianmin; Paneesha, Shankara; Willett, Brian; Moss, Paul; Parry, Helen.
Afiliação
  • Roberts T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Uwenedi G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • McIlroy G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Damery S; University Hospitals Birmingham, Edgbaston, Birmingham, B15 2GW, UK.
  • Sylla P; Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
  • Logan N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Scott S; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, G61 1QH, UK.
  • Lau M; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, G61 1QH, UK.
  • Elzaidi A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Plass S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Mallick S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Spencer K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Stephens C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Bentley C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Pratt G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Zuo J; University Hospitals Birmingham, Edgbaston, Birmingham, B15 2GW, UK.
  • Paneesha S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
  • Willett B; University Hospitals Birmingham, Edgbaston, Birmingham, B15 2GW, UK.
  • Moss P; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, G61 1QH, UK.
  • Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Blood Cancer J ; 14(1): 22, 2024 01 25.
Article em En | MEDLINE | ID: mdl-38272915
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido